BICYCLE THERAPEUTICS PLC-ADR
BCYCNASDAQ🏆 #2891 by market capEarnings Oct 29US Equity
$4.13▲ $0.03 (+0.73%)
Market closed · at close1h—
24h▲ 0.7%
7d▲ 4.0%
14d▲ 6.9%
30d▼ 4.8%
1y▼ 42.7%
🏦Market Cap
$287M
Small Cap
📈Revenue Growth (YoY)
+105.8%
High Growth
📊Gross Margin
100.0%
High
💵FCF Margin
-335.9%
Thin
⚖️P/S Ratio
4.7x
Fair
Otter Score
58
Weak
📊
Analyst Ratings
Price
$4.13
Total
21
Raised
1
Lowered
0
Avg PT
$10.67
H / L
$12 / $8
| Institution | Action | Rating | Date |
|---|---|---|---|
Needham | Reiterated | Buy | 2026-07-30 |
Morgan Stanley | Reiterated | Equal Weight | 2026-04-08 |
Citizens | Reiterated | Market Outperform | 2026-03-18 |
Oppenheimer | Reiterated | Outperform | 2026-03-18 |
RBC Capital | Reiterated | Sector Perform | 2026-03-18 |
JMP Securities | Reiterated | Market Outperform | 2025-08-12 |
B. Riley Securities | Reiterated | Neutral | 2025-05-02 |
Barclays | Reiterated | Overweight | 2025-05-01 |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-26 |
HC Wainwright & Co. | Reiterated | Buy | 2025-02-26 |
Stephens & Co. | Reiterated | Equal Weight | 2025-01-22 |
Canaccord Genuity | Reiterated | Buy | 2024-02-21 |
Cantor Fitzgerald | Reiterated | Overweight | 2023-11-08 |
EF Hutton | Reiterated | Buy | 2023-04-19 |
Cowen & Co. | Reiterated | Outperform | 2022-08-31 |
SVB Leerink | Reiterated | Outperform | 2022-08-22 |
Piper Sandler | Reiterated | Overweight | 2022-05-23 |
Roth Capital | Reiterated | Buy | 2019-11-14 |
Goldman Sachs | Upgraded | Neutral → Buy | 2019-09-11 |
Piper Jaffray | Reiterated | Overweight | 2019-06-17 |
Jefferies | Reiterated | Buy | 2019-06-17 |
One row per institution, most recent rating